Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers

We began analyzing https://link.springer.com/article/10.1007/s100670200099, but it redirected us to https://link.springer.com/article/10.1007/s100670200099. The analysis below is for the second page.

Title[redir]:
Influenza Virus Vaccination of Patients with SLE: Effects on Generation of Autoantibodies | Clinical Rheumatology
Description:
The sera of 24 women with SLE who received influenza vaccine were tested by ELISA for anti-DNA, anticardiolipin, anti-Sm, anti-Sm/RNP, anti-Ro and anti-La. Blood samples were withdrawn at the time of vaccination and 6 and 12 weeks after vaccination. The mean age at enrolment into the study was 46.1 years. The mean disease duration was 9.1 years. SLEDAI scores were 6.6 at vaccination, 4.9 at 6 weeks and 5.1 at week 12. The vaccine was not associated with the generation of anti-DNA. At time of vaccination a single patient had anti-Sm, four patients had anti-Sm/RNP antibodies, none of the patients had anti-La antibody and six had anti-Ro antibodies. Six weeks after vaccination four, eight, nine and three patients had autoantibodies reacting with Sm, Sm/RNP, Ro and La, respectively. Twelve weeks after vaccination none of the patients had anti-Sm, three had anti-Sm/RNP, five had anti-Ro and two had anti-La antibodies. Following vaccination six and three patients developed IgG and IgM anticardiolipin antibodies, respectively. In summary, although the influenza virus vaccine is clinically safe for patients with SLE it may trigger the generation of autoantibodies. This effect is usually short term and has no clinical significance.

Matching Content Categories {πŸ“š}

  • Science
  • News & Politics
  • Health & Fitness

Content Management System {πŸ“}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 8,445,319 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {πŸ’Έ}

We're unsure if the website is profiting.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Doi.org might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {πŸ”}

article, vaccination, influenza, patients, access, privacy, cookies, content, sle, information, publish, search, generation, autoantibodies, vaccine, weeks, antibodies, antibody, data, log, journal, research, clinical, virus, abushakra, press, sukenik, antism, antismrnp, antiro, antila, open, discover, springer, optional, personal, parties, policy, find, track, rheumatology, effects, published, cite, buskila, explore, received, antidna, anticardiolipin, time,

Topics {βœ’οΈ}

month download article/chapter influenza virus vaccination influenza virus vaccine received influenza vaccine trivalent influenza vaccine antibody response anti-la antibody full article pdf privacy choices/manage cookies anti-sm/rnp antibodies article abu-shakra european economic area scope submit manuscript related subjects ben-gurion university anti-dna conditions privacy policy check access instant access igm anticardiolipin antibodies accepting optional cookies anti-la antibodies anti-sm/rnp anti-ro antibodies main content log journal finder publish clinical significance patients developed igg article log article cite privacy policy personal data books a sm/rnp information optional cookies manage preferences anti-sm anti-la abu-shakra data protection essential cookies cookies skip autoantibodies reacting subscription content similar content anti-ro institution subscribe journal publish usage analysis

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Influenza Virus Vaccination of Patients with SLE: Effects on Generation of Autoantibodies
         description: The sera of 24 women with SLE who received influenza vaccine were tested by ELISA for anti-DNA, anticardiolipin, anti-Sm, anti-Sm/RNP, anti-Ro and anti-La. Blood samples were withdrawn at the time of vaccination and 6 and 12 weeks after vaccination. The mean age at enrolment into the study was 46.1 years. The mean disease duration was 9.1 years. SLEDAI scores were 6.6 at vaccination, 4.9 at 6 weeks and 5.1 at week 12. The vaccine was not associated with the generation of anti-DNA. At time of vaccination a single patient had anti-Sm, four patients had anti-Sm/RNP antibodies, none of the patients had anti-La antibody and six had anti-Ro antibodies. Six weeks after vaccination four, eight, nine and three patients had autoantibodies reacting with Sm, Sm/RNP, Ro and La, respectively. Twelve weeks after vaccination none of the patients had anti-Sm, three had anti-Sm/RNP, five had anti-Ro and two had anti-La antibodies. Following vaccination six and three patients developed IgG and IgM anticardiolipin antibodies, respectively. In summary, although the influenza virus vaccine is clinically safe for patients with SLE it may trigger the generation of autoantibodies. This effect is usually short term and has no clinical significance.
         datePublished:2014-05-12T00:00:00Z
         dateModified:2014-05-12T00:00:00Z
         pageStart:369
         pageEnd:372
         sameAs:https://doi.org/10.1007/s100670200099
         keywords:
            Key words:Autoantibodies – Influenza – SLE – Vaccination
            Rheumatology
         image:
         isPartOf:
            name:Clinical Rheumatology
            issn:
               1434-9949
               0770-3198
            volumeNumber:21
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:M. Abu-Shakra
               affiliation:
                     name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel
                     address:
                        name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. Press
               affiliation:
                     name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel
                     address:
                        name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S. Sukenik
               affiliation:
                     name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel
                     address:
                        name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
               name:D. Buskila
               affiliation:
                     name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel
                     address:
                        name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Influenza Virus Vaccination of Patients with SLE: Effects on Generation of Autoantibodies
      description: The sera of 24 women with SLE who received influenza vaccine were tested by ELISA for anti-DNA, anticardiolipin, anti-Sm, anti-Sm/RNP, anti-Ro and anti-La. Blood samples were withdrawn at the time of vaccination and 6 and 12 weeks after vaccination. The mean age at enrolment into the study was 46.1 years. The mean disease duration was 9.1 years. SLEDAI scores were 6.6 at vaccination, 4.9 at 6 weeks and 5.1 at week 12. The vaccine was not associated with the generation of anti-DNA. At time of vaccination a single patient had anti-Sm, four patients had anti-Sm/RNP antibodies, none of the patients had anti-La antibody and six had anti-Ro antibodies. Six weeks after vaccination four, eight, nine and three patients had autoantibodies reacting with Sm, Sm/RNP, Ro and La, respectively. Twelve weeks after vaccination none of the patients had anti-Sm, three had anti-Sm/RNP, five had anti-Ro and two had anti-La antibodies. Following vaccination six and three patients developed IgG and IgM anticardiolipin antibodies, respectively. In summary, although the influenza virus vaccine is clinically safe for patients with SLE it may trigger the generation of autoantibodies. This effect is usually short term and has no clinical significance.
      datePublished:2014-05-12T00:00:00Z
      dateModified:2014-05-12T00:00:00Z
      pageStart:369
      pageEnd:372
      sameAs:https://doi.org/10.1007/s100670200099
      keywords:
         Key words:Autoantibodies – Influenza – SLE – Vaccination
         Rheumatology
      image:
      isPartOf:
         name:Clinical Rheumatology
         issn:
            1434-9949
            0770-3198
         volumeNumber:21
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:M. Abu-Shakra
            affiliation:
                  name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel
                  address:
                     name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. Press
            affiliation:
                  name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel
                  address:
                     name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S. Sukenik
            affiliation:
                  name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel
                  address:
                     name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
            name:D. Buskila
            affiliation:
                  name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel
                  address:
                     name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Clinical Rheumatology
      issn:
         1434-9949
         0770-3198
      volumeNumber:21
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel
      address:
         name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
         type:PostalAddress
      name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel
      address:
         name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
         type:PostalAddress
      name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel
      address:
         name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
         type:PostalAddress
      name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel
      address:
         name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:M. Abu-Shakra
      affiliation:
            name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel
            address:
               name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
               type:PostalAddress
            type:Organization
      name:J. Press
      affiliation:
            name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel
            address:
               name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
               type:PostalAddress
            type:Organization
      name:S. Sukenik
      affiliation:
            name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel
            address:
               name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
               type:PostalAddress
            type:Organization
      name:D. Buskila
      affiliation:
            name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel
            address:
               name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
      name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
      name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
      name:Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel, Israel
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(71)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com
4.37s.